APOLLOHOSPBSEApollo Hospitals Enterprise LtdHighNeutral
Announced Wed, 20 May · 18:13 IST

as per annexure enclosed

Pat Growth 25pctRevenue Growth 20pctExceptional ItemRelated Party TransactionsDebt Equity ThresholdResults View source PDF

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.4%1-day move
₹8075.00
prior close
₹8198.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-0.7-0.2+1.9+3.4+4.2+2.4+2.5+1.8+0.6+5.3+4.9+10.4
Up moveDown movePending
AI summary

Apollo Hospitals Enterprise Limited reported strong FY2026 results with standalone revenue from operations growing 13.7% to Rs 93,262 million and consolidated revenue up 15.8% to Rs 252,285 million. Consolidated PAT surged 33% to Rs 20,027 million with EPS of Rs 135.04. The Board approved two major corporate actions: merger of wholly-owned subsidiary Apollo Hospitals North Limited into the company, and a transaction where Apollo Health and Lifestyle Limited divests stakes in Apollo Specialty Hospitals and Apollo Fertility Centre to Kids Clinic India (Cloudnine) at an enterprise value of Rs 15,500 million. Dr. Prathap C Reddy was re-appointed as Executive Chairman for two years, and Ms. Rama Bijapurkar's appointment as Independent Director was renewed for five years. Auditors issued unmodified opinions on both standalone and consolidated financials.

Likely market impact

Apollo Hospitals delivered robust 33% PAT growth on consolidated basis, signaling strong operational performance across healthcare services, retail health, and digital pharmacy segments. The strategic transactions and merger announcements indicate active portfolio restructuring. Shareholders can expect total dividend of Rs 20 per share for FY2026.